Shin-Ya Saito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shin-Ya Saito has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Tomohisa Ishikawa
Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Shizuoka, 422-8526, Japan
4 shared publications - Momoka Yamaguchi
Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka City, Shizuoka 422-8526, Japan
2 shared publications - Akira Ooka
School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan
1 shared publication Ayaka Horie
Department of Pharmacology, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka City, Japan
1 shared publicationEita Hishinuma
Department of Pharmacology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka City, Shizuoka 422-8526, Japan
1 shared publication- Haruhisa Kikuchi
Division of Natural Medicines, Faculty of Pharmacy, Keio University, Tokyo 105-8512, Japan
1 shared publication
Latest Publications
- Open Access
- 3 November 2021
- Published by Springer Nature in Renal Replacement Therapy
- Vol. 7 (1) , 1-8
Relationship between hemodialysis and health-related quality of life: a cross-sectional study of diagnosis and duration of hemodialysis
Background: Hemodialysis is a medical technology implemented for various renal diseases and has a significant budget impact in Japan. Hemodialysis also affects health-related quality of life, as it interferes with daily life, but the effect of diagnosis and duration of hemodialysis is not clear. The purpose of this study was to examine the impact of hemodialysis on health-related quality of life, with a focus on diagnosis and duration of hemodialysis. Methods: We conducted EQ-5D-5L surveys among hemodialysis patients at a single hemodialysis hospital between November 2015 and September 2017 and used a scoring algorithm that was developed in Japan to calculate the scores. Results: A total of 274 subjects without missing data were included in the data analysis. The mean score of the entire group was 0.772 ± 0.215. Compared with other domains, pain/discomfort had the highest percentage of problems (59.1%). There were no differences in the distributions with respect to diagnostic names in any domain. Multiple regression analysis showed that hemodialysis duration was the only explanatory variable that had a mild significant effect on EQ-5D-5L scores, but it was not large. Conclusions: QOL measured using the EQ-5D-5L survey score was not affected by age, gender, or diagnosis but was affected by hemodialysis duration. Future studies are needed to investigate the impact of prolonged hemodialysis on health-related quality of life.
- 3 November 2021
- Published by Springer Nature in Renal Replacement Therapy
- Vol. 7 (1) , 1-8
Open AccessRelationship between hemodialysis and health-related quality of life: a cross-sectional study of diagnosis and duration of hemodialysis
Background: Hemodialysis is a medical technology implemented for various renal diseases and has a significant budget impact in Japan. Hemodialysis also affects health-related quality of life, as it interferes with daily life, but the effect of diagnosis and duration of hemodialysis is not clear. The purpose of this study was to examine the impact of hemodialysis on health-related quality of life, with a focus on diagnosis and duration of hemodialysis. Methods: We conducted EQ-5D-5L surveys among hemodialysis patients at a single hemodialysis hospital between November 2015 and September 2017 and used a scoring algorithm that was developed in Japan to calculate the scores. Results: A total of 274 subjects without missing data were included in the data analysis. The mean score of the entire group was 0.772 ± 0.215. Compared with other domains, pain/discomfort had the highest percentage of problems (59.1%). There were no differences in the distributions with respect to diagnostic names in any domain. Multiple regression analysis showed that hemodialysis duration was the only explanatory variable that had a mild significant effect on EQ-5D-5L scores, but it was not large. Conclusions: QOL measured using the EQ-5D-5L survey score was not affected by age, gender, or diagnosis but was affected by hemodialysis duration. Future studies are needed to investigate the impact of prolonged hemodialysis on health-related quality of life.
- Open Access
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 1-10
Liver blood flow is regulated by hepatic stellate cells and sympathetic nerve in the sinusoid
The diameter of sinusoid has been shown to be changed by perfusion of adrenaline and acetylcholine. Thus, the liver blood flow is suggested to be regulated by the autonomic nervous systems in the sinusoid. However, it remains to be elucidated which cells in the sinusoid are involved in the response. The present study focused on hepatic stellate cells (HSCs) encircling the sinusoid and aimed to determine 1) whether HSCs constrict in response to noradrenaline (NAd) and 2) whether HSCs regulate liver blood flow. To measure HSC constriction quantitatively, we developed a novel method using fluorescent beads. We observed that HSCs constricted in response to NAd, which was suppressed by the α1-adrenoceptor inhibitor bunazosin and the non-muscle myosin II inhibitor blebbistatin (Bleb;1 µM). In contrast, Bleb (1 µM) had no effect on the contraction of isolated portal veins. The NAd-induced constriction of HSCs was also suppressed by xestospongin C, YM-58483, W-7, ML-9, and H-1152. In addition, Bleb (1 µM) decreased the perfusion pressure of the liver increased by NAd. This response appears to be due to HSC relaxation, since Bleb had the inhibitory effect on HSCs but not on portal veins. These results suggest that NAd induces constriction of HSCs via increasing Ca2+ influx and Ca2+ sensitization, thereby regulating liver blood flow.
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 1-10
Open AccessLiver blood flow is regulated by hepatic stellate cells and sympathetic nerve in the sinusoid
The diameter of sinusoid has been shown to be changed by perfusion of adrenaline and acetylcholine. Thus, the liver blood flow is suggested to be regulated by the autonomic nervous systems in the sinusoid. However, it remains to be elucidated which cells in the sinusoid are involved in the response. The present study focused on hepatic stellate cells (HSCs) encircling the sinusoid and aimed to determine 1) whether HSCs constrict in response to noradrenaline (NAd) and 2) whether HSCs regulate liver blood flow. To measure HSC constriction quantitatively, we developed a novel method using fluorescent beads. We observed that HSCs constricted in response to NAd, which was suppressed by the α1-adrenoceptor inhibitor bunazosin and the non-muscle myosin II inhibitor blebbistatin (Bleb;1 µM). In contrast, Bleb (1 µM) had no effect on the contraction of isolated portal veins. The NAd-induced constriction of HSCs was also suppressed by xestospongin C, YM-58483, W-7, ML-9, and H-1152. In addition, Bleb (1 µM) decreased the perfusion pressure of the liver increased by NAd. This response appears to be due to HSC relaxation, since Bleb had the inhibitory effect on HSCs but not on portal veins. These results suggest that NAd induces constriction of HSCs via increasing Ca2+ influx and Ca2+ sensitization, thereby regulating liver blood flow.
- 1 November 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 520 (1) , 140-144
Differentiation-inducing factor-1 prevents hepatic stellate cell activation through inhibiting GSK3β inactivation
- 1 November 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 520 (1) , 140-144
Differentiation-inducing factor-1 prevents hepatic stellate cell activation through inhibiting GSK3β inactivation
- 1 April 2019
- Published by Elsevier in European Journal of Pharmacology
- Vol. 849, 67-74
Alleviation of mechanical stress-induced allodynia by improving blood flow in chronic constriction injury mice
- 1 April 2019
- Published by Elsevier in European Journal of Pharmacology
- Vol. 849, 67-74
Alleviation of mechanical stress-induced allodynia by improving blood flow in chronic constriction injury mice
- 1 January 2004
- Published by Georg Thieme Verlag KG
- p. 1
Aluminum Fluorides
Science of Synthesis is your online synthetic methodology tool for the most reliable chemical transformations available!
- 1 January 2004
- Published by Georg Thieme Verlag KG
- p. 1
Aluminum Fluorides
Science of Synthesis is your online synthetic methodology tool for the most reliable chemical transformations available!
- Open Access
- 1 January 1999
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 24 (1) , 1-16
Recent progress in the neurotoxicology of natural drugs associated with dependence or addiction, their endogenous agonists and receptors.
Nicotine in tobacco, tetrahydrocannabinol (delta 9-THC) in marijuana and morphine in opium are well known as drugs associated with dependence or addiction. Endogenous active substances that mimic the effects of the natural drugs and their respective receptors have been found in the mammalian central nervous system (CNS). Such active substances and receptors include acetylcholine (ACh) and the nicotinic ACh receptor (nAChR) for nicotine, anandamide and CB1 for delta 9-THC, and endomorphins (1 and 2) and the mu (OP3) opioid receptor for morphine, respectively. Considerable progress has been made in studies on neurotoxicity, in terms of the habituation, dependence and withdrawal phenomena associated with these drugs and with respect to correlations with endogenous active substances and their receptors. In this article we shall review recent findings related to the neurotoxicity of tobacco, marijuana and opium, and their toxic ingredients, nicotine, delta 9-THC and morphine in relation to their respective endogenous agents and receptors in the CNS.
- 1 January 1999
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 24 (1) , 1-16
Open AccessRecent progress in the neurotoxicology of natural drugs associated with dependence or addiction, their endogenous agonists and receptors.
Nicotine in tobacco, tetrahydrocannabinol (delta 9-THC) in marijuana and morphine in opium are well known as drugs associated with dependence or addiction. Endogenous active substances that mimic the effects of the natural drugs and their respective receptors have been found in the mammalian central nervous system (CNS). Such active substances and receptors include acetylcholine (ACh) and the nicotinic ACh receptor (nAChR) for nicotine, anandamide and CB1 for delta 9-THC, and endomorphins (1 and 2) and the mu (OP3) opioid receptor for morphine, respectively. Considerable progress has been made in studies on neurotoxicity, in terms of the habituation, dependence and withdrawal phenomena associated with these drugs and with respect to correlations with endogenous active substances and their receptors. In this article we shall review recent findings related to the neurotoxicity of tobacco, marijuana and opium, and their toxic ingredients, nicotine, delta 9-THC and morphine in relation to their respective endogenous agents and receptors in the CNS.